Arcturus Therapeutics Secures $1,300,000 Seed Round

  • Feed Type
  • Date
    6/5/2013
  • Company Name
    Arcturus Therapeutics
  • Mailing Address
    3210 Merryfield Row San Diego, CA 92121
  • Company Description
    Arcturus Therapeutics is poised to become an industry leader in the application of RNAi technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment.
  • Website
    http://www.arcturusrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,300,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The new round of funding will support the purchase of capital equipment and further development of Arcturus’ intellectual property of RNAi delivery technologies, along with RNAi target selection, design and in vitro proof of concept studies.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.